Related Experiment Video
Updated: Mar 17, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte
Sergey Yechikov1, Raul Copaciu2, Jessica M Gluck1
1Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, California, USA.
Insights
This study investigated pacemaker-specific markers in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Pacemaker markers HCN4 and Isl1 were expressed in all subtypes, but not sufficient for identification.
Area of Science:
- Cardiology
- Stem Cell Biology
- Molecular Biology
Background:
- Identifying cardiomyocyte subtypes from human induced pluripotent stem cells (hiPSCs) is crucial for cardiac research.
- Current methods for subtype identification, like patch-clamp recordings, are destructive.
- Pacemaker-specific markers are needed to track differentiation and maturation of hiPSC-derived pacemaker-like cells.
Purpose of the Study:
- To assess the protein expression of proposed pacemaker-specific markers, HCN4 and Isl1, in hiPSC-derived cardiomyocyte subtypes.
- To develop a method for analyzing gene expression in single cells after optical action potential recording.
- To determine if HCN4 and Isl1 are sufficient for identifying hiPSC-derived pacemaker-like cardiomyocytes.
Main Methods:
- Developed a same-single-cell analysis technique combining optical action potential recording with subsequent immunostaining.
- Analyzed protein expression of HCN4 and Isl1 in hiPSC-derived pacemaker-, atrial-, and ventricular-like cardiomyocyte subtypes.
- Quantified marker expression over time to observe changes in differentiation and maturation.
Main Results:
- HCN4 and Isl1 proteins were detected in all three hiPSC-derived cardiomyocyte subtypes.
- HCN4 expression was initially higher in pacemaker-like cells but decreased over time.
- Isl1 expression showed a statistically significant increase in pacemaker-like cells compared to ventricular-like cells over time.
Conclusions:
- HCN4 and Isl1 are expressed in hiPSC-derived cardiomyocyte subtypes, but their expression patterns change during maturation.
- Differential expression of HCN4 and Isl1 exists between pacemaker-like and ventricular-like cells.
- HCN4 and Isl1 alone are insufficient markers for definitively identifying hiPSC-derived pacemaker-like cardiomyocytes.
Abstract:
Insights into the expression of pacemaker-specific markers in human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte subtypes can facilitate the enrichment and track differentiation and maturation of hiPSC-derived pacemaker-like cardiomyocytes. To date, no study has directly assessed gene expression in each pacemaker-, atria-, and ventricular-like cardiomyocyte subtype derived from hiPSCs since currently the subtypes of these immature cardiomyocytes can only be identified by action potential profiles. Traditional acquisition of action potentials using patch-clamp recordings renders the cells unviable for subsequent analysis. We circumvented these issues by acquiring the action potential profile of a single cell optically followed by assessment of protein expression through immunostaining in that same cell. Our same-single-cell analysis for the first time revealed expression of proposed pacemaker-specific markers-hyperpolarization-activated cyclic nucleotide-modulated (HCN)4 channel and Islet (Isl)1-at the protein level in all three hiPSC-derived cardiomyocyte subtypes. HCN4 expression was found to be higher in pacemaker-like hiPSC-derived cardiomyocytes than atrial- and ventricular-like subtypes but its downregulation over time in all subtypes diminished the differences. Isl1 expression in pacemaker-like hiPSC-derived cardiomyocytes was initially not statistically different than the contractile subtypes but did become statistically higher than ventricular-like cells with time. Our observations suggest that although HCN4 and Isl1 are differentially expressed in hiPSC-derived pacemaker-like relative to ventricular-like cardiomyocytes, these markers alone are insufficient in identifying hiPSC-derived pacemaker-like cardiomyocytes. Stem Cells 2016;34:2670-2680.
More Related Videos
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017
08:52Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015